CVS HEALTH Corp
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3014% above fair value
$88.51−1.74 (-1.93%)
Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%
Cvs Health Pharmacy & Consumer Wellness by Year
Pharmacy & Consumer Wellness — GAAP Operating Income ($M)
Cvs Health Pharmacy & Consumer Wellness: $4,860M in FY2025, up 1.9% from a year earlier.
Latest, FY2025
4,860
Period ended Dec 31, 2025
Change on a year earlier
+1.9%
4,770 in FY2024
History
9 years
Since FY2017
Sources
7
Documents cited below
Where the FY2025 figure comes from
“|| Operating income | 4,860 | 4,770 | 5,349 | 90 | 1.9 | % | (579) | (10.8) | %”
Source: CVS Health 10-K (2026-02-10) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Pharmacy & Consumer Wellness — GAAP Operating Income ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,860 | +1.9% | CVS Health 10-K (2026-02-10) ↗ |
| FY2024 | Dec 31, 2024 | 4,770 | -10.8% | CVS Health 10-K (2026-02-10) ↗ |
| FY2023 | Dec 31, 2023 | 5,349 | +50.3% | CVS Health 10-K (2026-02-10) ↗ |
| FY2022 | Dec 31, 2022 | 3,560 | -28.6% | CVS Health 10-K (2025-02-12) ↗ |
| FY2021 | Dec 31, 2021 | 4,984 | -11.6% | CVS Health 10-K (2024-02-07) ↗ |
| FY2020 | Dec 31, 2020 | 5,640 | -2.6% | CVS Health 10-K (2023-02-08) ↗ |
| FY2019 | Dec 31, 2019 | 5,793 | +834.4% | CVS Health 10-K (2022-02-09) ↗ |
| FY2018 | Dec 31, 2018 | 620 | -90.5% | CVS Health 10-K (2021-02-16) ↗ |
| FY2017 | Dec 31, 2017 | 6,558 | – | CVS Health 10-K (2020-02-18) ↗ |
Cite this data
StockData. (2026). Cvs Health Pharmacy & Consumer Wellness ($M), annual FY2017–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/pcw-opinc
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.